The main medicines that help with OCD are a class of antidepressants called SSRIs, which boost serotonin activity in the brain. These are the first-line treatment recommended by the American Psychiatric Association, and they reduce OCD symptoms in a meaningful way for many people. OCD typically requires higher doses and longer treatment windows than depression, so the medication journey looks a bit different than what you might expect.
SSRIs: The First Choice for OCD
Six SSRIs are currently used to treat OCD: fluoxetine (Prozac), sertraline (Zoloft), fluvoxamine (Luvox), paroxetine (Paxil), citalopram (Celexa), and escitalopram (Lexapro). These medications work by increasing the amount of serotonin available in your brain, which helps quiet overactive circuits that drive obsessive thoughts and compulsive behaviors. In OCD, a loop connecting the front of the brain to deeper structures tends to be hyperactive, and raising serotonin levels helps dial that activity down.
SSRIs are preferred over other options because they’re effective and relatively well tolerated. Side effects can include nausea, headache, sleep changes, and sexual dysfunction, but most people find them manageable compared to older alternatives. Your prescriber will typically start at a standard dose and increase gradually, because evidence shows that higher SSRI doses produce somewhat better response rates and greater symptom relief in OCD specifically.
Why OCD Needs Higher Doses and More Time
One of the most important things to know is that OCD treatment looks different from depression treatment. The doses that work for OCD are often at the upper end of the approved range. For example, the usual target dose of sertraline for OCD is 200 mg per day, and fluoxetine targets 40 to 60 mg per day. Some people benefit from going even higher than standard maximums, though this requires close monitoring.
The timeline is also longer. A proper trial of an SSRI for OCD requires 8 to 12 weeks, with at least 6 of those weeks at a moderate to high dose. That said, a meta-analysis published in The Journal of Clinical Psychiatry found that a statistically significant benefit over placebo appears within the first 2 weeks. By week 6, more than 75% of the short-term improvement has typically occurred. The catch is that progress can be gradual enough that you don’t notice it week to week. Improvement can also continue well beyond the 12-week mark, so patience matters.
Clomipramine: An Older but Potent Option
Clomipramine (Anafranil) is an older tricyclic antidepressant that was the first medication specifically studied for OCD. Some research suggests it’s slightly more effective than SSRIs, though other studies find them equivalent. Despite that edge, SSRIs are still preferred as a first try because clomipramine comes with a heavier side effect burden: dry mouth, constipation, drowsiness, weight gain, and dizziness are common. More seriously, overdose carries a risk of fatal cardiac arrest, which is not a concern with SSRIs.
Clomipramine is typically reserved for people who haven’t responded well to one or more SSRIs. The usual target dose ranges from 100 to 250 mg per day.
What Happens When SSRIs Don’t Work Enough
Not everyone gets adequate relief from an SSRI alone. When symptoms remain significant after a full trial at an appropriate dose, the most common next step is adding a low-dose atypical antipsychotic. This is called augmentation. The medications with the most evidence for this role include risperidone and aripiprazole, with quetiapine and olanzapine also studied. These are used at much lower doses than they would be for conditions like schizophrenia.
Augmentation doesn’t mean switching medications. You stay on your SSRI and add the second drug on top. This strategy targets the dopamine system in addition to serotonin, which makes sense given that both chemical messengers play roles in the brain circuits involved in OCD.
Medications for Children and Teens
Four medications are FDA-approved for OCD in children: clomipramine (approved from age 10), fluoxetine, fluvoxamine (both approved from age 8), and sertraline (approved from age 6). The same general principles apply: start low, increase gradually, and allow enough time at an adequate dose before judging whether the medication is working. For children especially, medication is often combined with a specific type of therapy called exposure and response prevention, which has strong evidence on its own and works even better alongside medication.
Off-Label Options Still Under Study
For people who haven’t responded to standard approaches, a few medications that affect a different brain chemical called glutamate have shown early promise. Memantine, a drug originally developed for Alzheimer’s disease, has been studied as an add-on to SSRIs in both children and adults. Case reports and small open-label studies suggest potential benefit, but no large controlled trials have confirmed this yet.
N-acetylcysteine (NAC), a supplement available without a prescription, has also shown limited evidence of helping some people with OCD when added to standard treatment. Clinical experience from several research groups suggests it may benefit at least a subset of patients. These options are best considered a last resort after established treatments have been fully tried, and they should be discussed with a prescriber rather than pursued independently.
How Long You Stay on Medication
OCD is typically a long-term condition, and medication is generally continued for an extended period after symptoms improve. Stopping too early carries a significant risk of relapse. Most guidelines recommend staying on your effective dose for at least one to two years before considering a gradual taper, and many people with OCD remain on medication indefinitely because the benefits continue as long as they’re taking it. If you and your prescriber do decide to reduce your dose, it should be done slowly, not abruptly, to minimize the chance of symptoms returning.